Your browser doesn't support javascript.
loading
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.
Baecklund, Fredrik; Ekberg, Sara; Rosenquist, Richard; Askling, Johan; Eloranta, Sandra; Smedby, Karin E.
Afiliação
  • Baecklund F; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
  • Ekberg S; Pediatric Oncology Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Rosenquist R; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
  • Askling J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Eloranta S; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  • Smedby KE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Eur J Haematol ; 105(6): 779-785, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32871627
ABSTRACT

OBJECTIVES:

To investigate concordance in survival time among first-degree relatives with lymphoid malignancies.

METHODS:

By linkage of national Swedish registers, we identified 66 430 patients diagnosed with a lymphoid malignancy 1958-2016 with information on first-degree relationships and follow-up until 2017. Among these, we identified pairs of first-degree relatives with any (N = 3326) or a similar (N = 690) lymphoid malignancy subtype. We defined survival in the first-degree relative as good, expected, or poor based on tertiles of deviance residuals from a multivariable Cox regression model. Next, we used Cox regression to estimate hazard ratios (HR) of death with 95% confidence intervals (CI) among patients, using the survival of their first-degree relative as exposure and adjusting for confounders.

RESULTS:

There was no concordance in survival among first-degree relatives with any lymphoid malignancy (HRgood  = 1.00 (reference), HRExpected  = 1.02, 95% CI 0.89-1.17, HRPoor  = 1.12, 95% CI 0.98-1.27, Ptrend  = .08). Among first-degree relatives with indolent lymphoma, including chronic lymphocytic leukemia, those with a first-degree relative to an expected or poor survival had worse outcome compared to those with a first-degree relative with good survival (HRExpected  = 1.44, 95% CI 0.82-2.53, HRPoor  = 1.79, 95% CI 1.07-3.00, Ptrend  = .03).

CONCLUSION:

Our results support a role of inherited factors in the outcome of indolent lymphoma, including chronic lymphocytic leukemia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Núcleo Familiar / Transtornos Linfoproliferativos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Núcleo Familiar / Transtornos Linfoproliferativos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article